An artemisinin derivative is derived from Artemisia annua, also known as sweet wormwood, and is known to rapidly and effectively reduce plasmodium parasites in the blood of malaria patients. Treatment with artemisinin is effective against Plasmodium falciparum malaria. The drug artemisinin, as well as its derivatives, has been used for treating parasitic infections including malaria and parasitic worms (helminths). These drugs have the advantage of killing parasites at every stage of their life cycle, compared to other drugs. However, low bioavailability, poor pharmacokinetics, and high cost of the drugs make their use unpopular. At the doses used to treat malaria, artemisinins are generally well tolerated. The side effects of the artemisinin class of medications are similar to those of malaria: nausea, vomiting, dizziness, and loss of appetite. Mild blood abnormalities have been reported as well. Most malaria cases are caused by Plasmodium falciparum. Because of the high prevalence of malaria, this market is growing rapidly.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Artemisinin Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Artemisinin Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.